vimarsana.com

Page 34 - தொழிற்சங்கம் ஆரோக்கியம் செயலாளர் ராஜேஷ் பூஷன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus Latest News LIVE Updates: Covaxin effective against Indian, UK COVID-19 strains, says Bharat Biotech

Adhere To Approved Categories Of Frontline Workers For Vaccination: Centre To States

Adhere to approved categories of frontline workers for Covid vaccination: Centre to states

Adhere to approved categories of frontline workers for Covid vaccination: Centre to states SECTIONS Last Updated: May 15, 2021, 10:59 PM IST Share Synopsis The missive from Union Health Secretary Rajesh Bhushan came after states like Odisha included railway staff, forest guards, oxygen plant employees and other categories as front line workers (FLW). PTI 3,353,630.0 The Centre has asked states and union territories to refrain from approving additional categories as frontline workers for vaccination, and recommended doing so using only vaccines procured directly by them. The missive from Union Health Secretary Rajesh Bhushan came after states like Odisha included railway staff, forest guards, oxygen plant employees and other categories as front line workers (FLW).

India vaccination drive: Government affidavit shows low May stock for 18-44 category; states asked t- The New Indian Express

India vaccination drive: Government affidavit shows low May stock for 18-44 category; states asked to focus on those needing second dose The affidavit shows that 1.5 crore doses of Covishield and 50 lakh doses of Covaxin are available in May for other than Government of India channel  in May. Share Via Email   |  A+A A- A woman gets herself photographed after getting vaccinated at a selfie point erected to create awareness on COVID-19 vaccination in Mumbai. (Photo | AP) Express News Service NEW DELHI:  Only about 2 crore Covid-19 vaccine doses may be available for the 18-44-year age group across India this month, an affidavit filed by the Centre in the Supreme Court revealed. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.